These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23792409)

  • 41. Prevalence of autoantibodies in type 1 diabetes mellitus pediatrics in Mazandaran, North of Iran.
    Zamanfar D; Aarabi M; Amini M; Monajati M
    J Pediatr Endocrinol Metab; 2020 Aug; 33(10):1299-1305. PubMed ID: 32809953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of autoimmune type 1 diabetes and multiple organ-specific autoantibodies in adult-onset non-insulin-requiring diabetes in China: A population-based multicentre nationwide survey.
    Xiang Y; Huang G; Zhu Y; Zuo X; Liu X; Feng Q; Li X; Yang T; Lu J; Shan Z; Liu J; Tian H; Ji Q; Zhu D; Ge J; Lin L; Chen L; Guo X; Zhao Z; Li Q; Weng J; Jia W; Liu Z; Ji L; Yang W; Leslie RD; Zhou Z;
    Diabetes Obes Metab; 2019 Apr; 21(4):893-902. PubMed ID: 30471182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.
    Maioli M; Alejandro E; Tonolo G; Gilliam LK; Bekris L; Hampe CS; Obinu DA; Manconi A; Puddu L; Lynch K; Lernmark A;
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5675-82. PubMed ID: 15531528
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children.
    Salami F; Tamura R; You L; Lernmark Å; Larsson HE; Lundgren M; Krischer J; Ziegler AG; Toppari J; Veijola R; Rewers M; Haller MJ; Hagopian W; Akolkar B; Törn C;
    Pediatr Diabetes; 2022 Dec; 23(8):1586-1593. PubMed ID: 36082496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Older age of childhood type 1 diabetes onset is associated with islet autoantibody positivity >30 years later: the Pittsburgh Epidemiology of Diabetes Complications Study.
    Miller RG; Yu L; Becker DJ; Orchard TJ; Costacou T
    Diabet Med; 2020 Aug; 37(8):1386-1394. PubMed ID: 32011014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
    Bonifacio E; Atkinson M; Eisenbarth G; Serreze D; Kay TW; Lee-Chan E; Singh B
    Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study).
    Takeda H; Kawasaki E; Shimizu I; Konoue E; Fujiyama M; Murao S; Tanaka K; Mori K; Tarumi Y; Seto I; Fujii Y; Kato K; Kondo S; Takada Y; Kitsuki N; Kaino Y; Kida K; Hashimoto N; Yamane Y; Yamawaki T; Onuma H; Nishimiya T; Osawa H; Saito Y; Makino H;
    Diabetes Care; 2002 Jun; 25(6):995-1001. PubMed ID: 12032105
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma-associated antigen-2 autoantibodies in the identification and characterization of Japanese type 1 diabetes.
    Kawasaki E; Oikawa Y; Okada A; Kanatsuna N; Kawamura T; Kikuchi T; Terasaki J; Miura J; Ito Y; Hanafusa T
    J Diabetes Investig; 2020 Sep; 11(5):1181-1187. PubMed ID: 32175683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Change of glutamic acid decarboxylase antibody and protein tyrosine phosphatase antibody in Chinese patients with acute-onset type 1 diabetes mellitus.
    Chao C; Huang G; Li X; Yang L; Lin J; Jin P; Luo SM; Zhang YY; Pan LL; Zhou ZG
    Chin Med J (Engl); 2013 Nov; 126(21):4006-12. PubMed ID: 24229665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group.
    Imagawa A; Hanafusa T; Miyagawa J; Matsuzawa Y
    N Engl J Med; 2000 Feb; 342(5):301-7. PubMed ID: 10655528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Frequency of pancreatic beta-cell autoimmunity markers in patients with autoimmune thyroid disease.
    Primo ME; Niepomniszcze H; Poskus E; Sala MS; Guaita SS; Sica MP; Villalba A; Cardoso A; Bruno OD
    Medicina (B Aires); 2008; 68(1):37-42. PubMed ID: 18416318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The broad clinical phenotype of Type 1 diabetes at presentation.
    Merger SR; Leslie RD; Boehm BO
    Diabet Med; 2013 Feb; 30(2):170-8. PubMed ID: 23075321
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carboxypeptidase-H autoantibodies differentiate a more latent subset of autoimmune diabetes from phenotypic type 2 diabetes among Chinese adults.
    Yang L; Zhou ZG; Tan SZ; Huang G; Jin P; Yan X; Li X; Peng H; Hagopian W
    Ann N Y Acad Sci; 2008 Dec; 1150():263-6. PubMed ID: 19120309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71).
    Bottazzo GF; Bosi E; Cull CA; Bonifacio E; Locatelli M; Zimmet P; Mackay IR; Holman RR
    Diabetologia; 2005 Apr; 48(4):703-8. PubMed ID: 15765222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of Unique Antigenic Determinants in the Amino Terminus of IA-2 (ICA512) in Childhood and Adult Autoimmune Diabetes: New Biomarker Development.
    Acevedo-Calado M; James EA; Morran MP; Pietropaolo SL; Ouyang Q; Arribas-Layton D; Songini M; Liguori M; Casu A; Auchus RJ; Huang S; Yu L; Michels A; Gianani R; Pietropaolo M
    Diabetes Care; 2017 Apr; 40(4):561-568. PubMed ID: 28174261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
    Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
    Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease.
    Tuomi T; Groop LC; Zimmet PZ; Rowley MJ; Knowles W; Mackay IR
    Diabetes; 1993 Feb; 42(2):359-62. PubMed ID: 8425674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The evaluation of thyroid and islet autoantibodies in type 1 diabetes mellitus.
    Prázný M; Skrha J; Límanová Z; Hilgertová J
    Sb Lek; 1999; 100(3):205-11. PubMed ID: 11221467
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dietary risk factors for the emergence of type 1 diabetes-related autoantibodies in 21/2 year-old Swedish children.
    Wahlberg J; Vaarala O; Ludvigsson J;
    Br J Nutr; 2006 Mar; 95(3):603-8. PubMed ID: 16578935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis.
    Redondo MJ; Rodriguez LM; Escalante M; Smith EO; Balasubramanyam A; Haymond MW
    Pediatr Diabetes; 2013 Aug; 14(5):333-40. PubMed ID: 23458188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.